The approach to soft tissue augmentation has evolved dramatically in recent years. With a greater appreciation for changes in facial soft tissue contours that occur with age has come an expansion of the role for fillers in rejuvenation of the midface. Ove
Different injectable products have highly divergent properties, associated risks, and injection requirements. The der- masurgeon should be suitably experienced to select and use these products correctly.
At week 24, mean improvement in WSRS from baseline was 2.09 0.68 for the PLA side and 1.54 0.65 for the HA side. Both injections were well toler- ated, and the adverse reactions were mild and transient in most cases. PLA provides noninferior efficac
